A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Market average: 76.5
Software average: 81.4
Overall performance score (100-point scale) |
Trend (2021-2022) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
||
Bluesight
Kit Check Bluesight for Controlled Substances |
90.9 |
+1%
|
n=30
|
A-
|
A
|
A-
|
A-
|
A-
|
A
|
|
|
|
|
|
|
||||||
Bluesight
Medacist RxAuditor Investigate / RxAuditor |
63.0 |
-9%
|
n=21
|
C
|
F
|
D+
|
D
|
C-
|
C-
|
|
50.0 |
100.0 |
Overall Performance Score (100-point scale) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
|
HelioMetrics
Drug Diversion Analytics L |
86.8 |
n=9
|
B+
|
B+
|
B
|
B
|
B+
|
A
|
|
|
|
|
|
||||
Imprivata
Drug Diversion Intelligence L |
68.3 |
n=10
|
F
|
C-
|
C
|
D+
|
C
|
C+
|
|
|
|
|
|
||||
Omnicell
Analytics L |
70 |
n=12
|
C
|
D
|
C
|
C
|
B
|
D-
|
|
|
|
|
|
||||
Protenus
Diversion Analytics L |
87.5 |
n=8
|
B
|
A
|
B
|
B+
|
B
|
A
|
Drug Diversion Analytics L
n=9
Drug Diversion Intelligence L
n=10
Analytics L
n=12
Diversion Analytics L
n=8